SEC Form D · filed August 3, 2020
AmbAgon Therapeutics Inc
Location
SAN FRANCISCO, CA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (23)
Joseph King · Chicago, ILDirectorJ. E. Virtue · New York, NYDirectorDavid Festi · Washington, PADirectorRichard Wahlstedt · Chicago, ILDirectorRoel Bulthuis · San Francisco, CADirectorLawrence J. Konis · Santa Monica, CAExecMark D. Allsteadt · NORWALK, CTDirectorJoshua Merrill · San Francisco, CAExecAdam Rosenberg · San Francisco, CADirectorMichelle Arkin · San Francisco, CAExec · DirectorMamoon Hamid · San Francisco, CADirectorPeter Dudek · San Francisco, CADirectorLucas Brunsveld · San Francisco, CAExecYaniv Tepper · Los Angeles, CADirectorJanwillem Naesens · San Francisco, CADirectorDonald R. Young · Northborough, MADirectorLucas Brunsveld · San Francisco, CAExecCraig Kautsch · Fort Worth, TXExec · DirectorAndrew E. Spring · New York, NYExec · DirectorSteven R. Mitchell · Northborough, MADirectorMargarita Chavez · San Francisco, CADirectorAjay Gupta · CHRISTCHURCH, Q2DirectorChristian Ottmann · San Francisco, CAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗